In vivo experiments indicated that Remodelin combined with anti-CTLA-4 therapy experienced a superior therapeutic outcome when compared with either treatment alone. In the end, we verified that the expression of NAT10 exhibited a beneficial correlation with the expression of PD-L1 in various forms of tumors, serving as an indicator of unfavorable p